Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes.
about
hiPSC-derived iMSCs: NextGen MSCs as an advanced therapeutically active cell resource for regenerative medicineClinical Potentials of Cardiomyocytes Derived from Patient-Specific Induced Pluripotent Stem CellsInduced pluripotent stem cell potential in medicine, specifically focused on reproductive medicineImproved bi-allelic modification of a transcriptionally silent locus in patient-derived iPSC by Cas9 nickaseHuman 45,X fibroblast transcriptome reveals distinct differentially expressed genes including long noncoding RNAs potentially associated with the pathophysiology of Turner syndrome.Generation of the SCN1A epilepsy mutation in hiPS cells using the TALEN technique.Human germ cell formation in xenotransplants of induced pluripotent stem cells carrying X chromosome aneuploidiesProduction of de novo cardiomyocytes: human pluripotent stem cell differentiation and direct reprogramming.Generation of human induced pluripotent stem cells from urine samples.Long QT interval in Turner syndrome--a high prevalence of LQTS gene mutationsGene expression analysis of induced pluripotent stem cells from aneuploid chromosomal syndromes.Comparing ESC and iPSC-Based Models for Human Genetic DisordersHuman pluripotent stem cells: applications and challenges in neurological diseases.New lessons learned from disease modeling with induced pluripotent stem cells.Uniparental disomy of the entire X chromosome in Turner syndrome patient-specific induced pluripotent stem cellsSustained knockdown of a disease-causing gene in patient-specific induced pluripotent stem cells using lentiviral vector-based gene therapy.Generation of Human Liver Chimeric Mice with Hepatocytes from Familial Hypercholesterolemia Induced Pluripotent Stem Cells.Pluripotent stem cells in disease modelling and drug discovery.Nutrient supplemented serum-free medium increases cardiomyogenesis efficiency of human pluripotent stem cells.Connexin 43 is involved in the generation of human-induced pluripotent stem cells.Modeling induced pluripotent stem cells from fibroblasts of Duchenne muscular dystrophy patients.Protein profiling identified key chemokines that regulate the maintenance of human pluripotent stem cells.Time-course transcriptome analysis of human cellular reprogramming from multiple cell types reveals the drastic change occurs between the mid phase and the late phase.Genome-wide analysis of PDX1 target genes in human pancreatic progenitors.Epigenetics in Turner syndrome.Recent Developments in Diagnosis and Care for Girls in Turner Syndrome
P2860
Q54836026-A555FB33-1718-4D06-B7A1-C9555165F673Q54836480-D81ADB9B-AA78-4451-B7D2-D0F64B015037Q54836686-DB53BFA4-D19D-4E3D-B63C-D28DE7796C81Q54837567-D304E5EA-8B66-4D54-9B6E-DCEAA029A7A9Q54838009-4ACE9486-8415-4DB4-A0B7-1C064FAC80A9Q54844866-11C963CE-3A23-41BD-99F9-F9D62A320F1AQ93324890-459CB8E9-39DF-41CA-8AB2-97C560481EC9Q93455410-2EC3E1A2-B1D5-4D52-B933-1B3CF3D4AB80Q93455411-6A471403-7163-4F53-A767-28E87F461FEFQ93525645-56434EE0-ABEF-4391-87FD-46E11A69A4BEQ93525652-024ED9EA-A811-4CA0-A341-42A55F7A88E3
P1343
Q26751506-60B54080-6CF4-44B2-B4F1-9A00044F236AQ27021919-B72A7FC9-6D30-4B22-B835-422816ED2898Q28083057-AF4AF393-07E6-426B-A8A7-1CB82ADEF5D4Q29114083-EA3A2117-C597-419F-8446-515C646CE3ACQ33763587-2766D2D5-B54D-4B55-B8BF-5C2F8BF702F3Q33788935-D0C42D12-925B-48D7-8F67-D16AF6FC5D41Q34219813-1C133FC1-B9BC-4DEA-8803-86D3C1D03E6BQ34245487-5E454BE2-41A6-4284-815D-1C4E421035C3Q34310664-AEB728A5-4874-40F8-AFBA-401469EDCEBCQ34920627-AE75EE0B-C174-42E1-BA2B-5EEECE7C53B7Q35101795-5649AEF3-9514-4415-9990-6D9F2902F806Q35750530-0A335ED2-8161-4648-9CA2-7DFFEFA0496DQ36193696-888DEBEF-6753-4514-A6D7-B3DF499BD58FQ36374130-34445ED5-582C-4F4D-9679-FFF5F7DD7237Q36882709-58324DD9-4355-48ED-8CDF-CBEFA18657B9Q37124547-A4EF2FD7-023E-4959-BAEE-2D9E0F706158Q37707720-41E1B8CF-EE94-4AAB-A57F-51AA79AAA1E7Q38714328-92CEC31F-9EEB-48CA-8F7A-6549381A5A87Q39117206-75D653B6-ED0E-4F1F-8D46-BFED672971EDQ39192308-B422E32A-0298-4DFC-83CB-AC957DC68D90Q44227546-F905C4FC-7CF7-4253-A5A6-6FE547C8C4CBQ45629246-140902CD-CCFB-4C7D-9F8F-7D2D5E833DBAQ47157700-1C7F5FC5-D2A1-4E96-A94F-71FA8F87EA4BQ49358937-2DC5FFE9-DF37-43EF-98D0-8D509A125FBEQ54970317-458E1CDD-B90C-48D5-9EA5-D8FBEC5D0B7EQ59043917-03B79729-EF5E-4684-AACE-7A7ECB227F51
P2860
Modeling abnormal early development with induced pluripotent stem cells from aneuploid syndromes.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh
2011年學術文章
@zh-hant
name
Modeling abnormal early develo ...... ells from aneuploid syndromes.
@en
Modeling abnormal early develo ...... ells from aneuploid syndromes.
@nl
type
label
Modeling abnormal early develo ...... ells from aneuploid syndromes.
@en
Modeling abnormal early develo ...... ells from aneuploid syndromes.
@nl
prefLabel
Modeling abnormal early develo ...... ells from aneuploid syndromes.
@en
Modeling abnormal early develo ...... ells from aneuploid syndromes.
@nl
P2093
P2860
P356
P1476
Modeling abnormal early develo ...... ells from aneuploid syndromes.
@en
P2093
Axel Schambach
Bjorn Menten
Dajiang Qin
Daniela Zychlinski
Dirk Hoffmann
Duanqing Pei
Hung-Fat Tse
Jiayin Yang
Jinglei Cai
P2860
P356
10.1093/HMG/DDR435
P50
P577
2011-09-23T00:00:00Z